Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rabey

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Current Medicinal Chemistry|June 6, 2012
Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosisF M Rabey, R S V S Gadepalli, S Diano, et al.
Applied Physics. B, Lasers and Optics|May 2, 2020
Design and fabrication of diffractive atom chips for laser cooling and trappingJ P Cotter, J P McGilligan, P F Griffin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesiaA Rapaport, M Sadeh, D Stein, et al.
Journal of Neuro-Oncology|June 9, 1999
Radiation therapy of metastatic spinal cord compression. Multidisciplinary team diagnosis and treatmentF Kovner, S Spigel, I Rider, et al.
Clinical Neuropharmacology|August 1, 1997
Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trialsJ M Rabey, H Bass, U Bonuccelli, et al.
Molecular Neurodegeneration|June 2, 2012
A molecular signature in blood identifies early Parkinson's diseaseLeonid Molochnikov, Jose M Rabey, Evgenya Dobronevsky, et al.
Journal of Neurology|July 22, 2015
Frequent misdiagnosis of adult polyglucosan body diseaseMark A Hellmann, Or Kakhlon, Ezekiel H Landau, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 8, 2011
High prevalence of malignant melanoma in Israeli patients with Parkinson's diseaseR Inzelberg, J M Rabey, E Melamed, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Current Medicinal Chemistry|June 6, 2012
Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosisF M Rabey, R S V S Gadepalli, S Diano, et al.
Applied Physics. B, Lasers and Optics|May 2, 2020
Design and fabrication of diffractive atom chips for laser cooling and trappingJ P Cotter, J P McGilligan, P F Griffin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesiaA Rapaport, M Sadeh, D Stein, et al.
Journal of Neuro-Oncology|June 9, 1999
Radiation therapy of metastatic spinal cord compression. Multidisciplinary team diagnosis and treatmentF Kovner, S Spigel, I Rider, et al.
Clinical Neuropharmacology|August 1, 1997
Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trialsJ M Rabey, H Bass, U Bonuccelli, et al.
Molecular Neurodegeneration|June 2, 2012
A molecular signature in blood identifies early Parkinson's diseaseLeonid Molochnikov, Jose M Rabey, Evgenya Dobronevsky, et al.
Journal of Neurology|July 22, 2015
Frequent misdiagnosis of adult polyglucosan body diseaseMark A Hellmann, Or Kakhlon, Ezekiel H Landau, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 8, 2011
High prevalence of malignant melanoma in Israeli patients with Parkinson's diseaseR Inzelberg, J M Rabey, E Melamed, et al.
Pageof 13